Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Archives

You are currently viewing the 2011 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: ASACOL HD

« Back to Dashboard

Summary for Tradename: ASACOL HD

Patents:3
Applicants:1
NDAs:1
Suppliers: see list1

Pharmacology for Tradename: ASACOL HD

Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate

Clinical Trials for: ASACOL HD

An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
Status: Completed Condition: Ankylosing Spondylitis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott Llc
ASACOL HD
mesalamine
TABLET, DELAYED RELEASE; ORAL021830May 29, 2008RXYes5,541,171<disabled>Y<disabled>
Warner Chilcott Llc
ASACOL HD
mesalamine
TABLET, DELAYED RELEASE; ORAL021830May 29, 2008RXYes5,541,170<disabled>Y<disabled>
Warner Chilcott Llc
ASACOL HD
mesalamine
TABLET, DELAYED RELEASE; ORAL021830May 29, 2008RXYes6,893,662<disabled>Y<disabled>
Warner Chilcott Llc
ASACOL HD
mesalamine
TABLET, DELAYED RELEASE; ORAL021830May 29, 2008RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ASACOL HD

Drugname Dosage Strength RLD Submissiondate
mesalamineDelayed-release Tablets800 mgAsacol HD7/13/2011
« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc